So have Kinder Morgan's political dealings in BC had a direct
impact on this approval?
And, your age may have
an impact on your approval for coverage.
Not exact matches
«That is going to cause turbo acceleration of the income, because that is 56 percent of the market in the biggest territory and that will have a massive
impact on sales from 2019,» de Winkel said, adding that a U.S.
approval could come early next year.
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses
on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect
on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions
on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory
approvals, including our ability to obtain in a timely fashion any required regulatory or other third party
approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse
impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse
impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns
on pension plan assets and the
impact of future discount rate changes
on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco
on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted
on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence
on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments
on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest
on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or
impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
Certain matters discussed in this news release are forward - looking statements that involve a number of risks and uncertainties including, but not limited to, doubts about the Company's ability to continue as a going concern, the need to obtain additional funding, risks in product development plans and schedules, rapid technological change, changes and delays in product
approval and introduction, customer acceptance of new products, the
impact of competitive products and pricing, market acceptance, the lengthy sales cycle, proprietary rights of the Company and its competitors, risk of operations in Israel, government regulations, dependence
on third parties to manufacture products, general economic conditions and other risk factors detailed in the Company's filings with the United States Securities and Exchange Commission.
• The prospect understands the full
impact your solution could have
on his business • The prospect has decision - making authority • You know and understand the
approval process • The prospect understands your pricing
Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the
impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature,
impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the
impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU,
on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted
on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory
approvals (and the risk that such
approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition
on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger
on the market price of United Technologies» and / or Rockwell Collins» common stock and / or
on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.
With
approval of the Keystone Pipeline it could mean more Canadian crude oil is coming to the U.S. CNBC's Jackie DeAngelis is in Nebraska, at the pipeline pumping station with a look at its
impact on oil prices and exports.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required
on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory
approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange
impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
It adds that «
approval or denial of the proposed project is unlikely to have a substantial
impact on the rate of development in the oil sands, or
on the amount of heavy crude oil refined in the Gulf Coast area.»
Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the
impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory
approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory
approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects
on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report
on Form 10 - K and subsequent reports
on Forms 10 - Q and 8 - K available
on the Investor Relations section of www.cigna.com as well as
on Express Scripts» most recent report
on Form 10 - K and subsequent reports
on Forms 10 - Q and 8 - K available
on the Investor Relations section of www.express-scripts.com.
Prior to local project
approvals, you'll provide the public with a detailed, verified Community
Impact Report regarding the project's
impacts on jobs, small businesses, housing, the treasury, the environment and public health; and
«While the consensus view is that FDA
approval will occur, the
impact such a decision will have
on current DEA scheduling remains in question,» Karnes said.
Statements regarding future events are based
on the parties» current expectations and are necessarily subject to associated risks related to, among other things, regulatory
approval of the proposed acquisition or that other conditions to the closing of the deal may not be satisfied, the potential
impact on the business of WhatsApp due to the announcement of the acquisition, the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive agreement, and general economic conditions.
Many Millennial buyers worry about the
impact of high student loans will have
on their
approval.
To put these numbers into perspective it is useful to consider the likely
impact on credit growth of the 5 per cent decline in the value of housing loan
approvals recorded in November 2003.
These risks, delays, and uncertainties include, but are not limited to: risks associated with the uncertainty of future financial results, our reliance
on our sole supplier, the limited diversification of our product offerings, additional financing requirements, development of new products, government
approval processes, the
impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.
• A recommendation to provide for mandatory notification to the ACCC for
approval of store acquisitions by the major chains and others (such as wholesalers Davids, FAL etc), with a requirement that the ACCC consult with local authorities and other relevant parties in order to make an informed assessment of the competitive
impact on local businesses of such acquisitions.
But the mayor said the Village Board would not begin formal consideration of the park district «s request until trustees give final
approval to the
impact fees for District 140, as they are expected to do
on Tuesday.
«In February I put together a very detailed PLP brief for the EU referendum campaign
on the
impact of Brexit
on the environment, with some input from the shadow DECC team too, and submitted it for
approval.
Gov. Andrew Cuomo's budget is relying
on the waiver to aid failing hospitals, but the
approval also
impacts items in his out - year budget planning.
But any law
impacting the Port Authority requires
approval by both state legislatures, and in New Jersey, both houses are controlled by Democrats who may be less - than - eager to sign
on to a Christie - backed reform package.
Meanwhile, the piece of legislation that could have the greatest
impact on rent that is being backed by advocates would change the requirements for serving
on the Rent Guidelines Board — the group that sets the rates for rent - controlled apartments and give the City Council
approval over the Mayor's appointments to the body.
Gov. Andrew Cuomo in an interview
on Sunday called his effort to gain more «flexibility» over the budget after its
approval a «major sticking point» with lawmakers, but a necessary move given the potential for federal actions that could negatively
impact the state.
The expected
approval of the $ 15 wage — which will be phased in over a number of years
on a different timetable in New York City and elsewhere in the state — is expected to bring a more concerted legislative effort next year to
impact low - wage workers across the board.
ALBANY — Gov. Cuomo's proposal for a $ 15 minimum wage will not win
approval unless the governor does more to offset the
impact on businesses, the leader of the GOP - controlled Senate said Monday.
Last June, the Cuomo Administration appeared to put
approval of fracking
on a fast track, moving ahead with an environmental
impact statement and setting up a time line that could have led to permits by the end of 2011.
«The decision to deny the
approvals necessary for the construction of the Constitution Pipeline will have a direct and immediate negative
impact on our state's economy.»
From President Donald Trump to New Jersey Governor Chris Christie, whose base has deteriorated, Poll Hub assesses what their job
approval rating means for the GOP moving forward and the
impact on the 2017 gubernatorial races in New Jersey and Virginia.
And Cuomo says the internal health review could result in hastening an
approval of fracking, because it will cut down
on the time spent fighting lawsuits that are expected to be filed once the final environmental
impact report is released.
Table: Governor Andrew Cuomo
Approval Rating Table: Governor Andrew Cuomo
Approval Rating Over Time Table: Governor Andrew Cuomo Favorability Table: Governor Andrew Cuomo Favorability Over Time Table: Governor Andrew Cuomo as Leader Table: Governor Andrew Cuomo as Leader Over Time Table: Governor Andrew Cuomo as Fulfilling Campaign Promises Table: Governor Andrew Cuomo as Fulfilling Campaign Promises Over Time Table: Governor Andrew Cuomo's
Impact on Albany Table: Governor Andrew Cuomo's
Impact on Albany Over Time
The Planning Board conducted a review of the project and
on September 10 issued a «negative declaration» under State Environmental Quality Review Act (SEQRA) review, meaning that the Planning Board found that there would be no significant adverse environmental
impacts from the project, and issued a «preliminary» site plan
approval of the project subject to Zoning Board of Appeals (ZBA) review of «performance standards.»
Wang acknowledged that possibility in a 7 September interview with Caijing magazine: «opposing voices naturally have an
impact on future
approval of the project,» he said.
Gaining
approval could mean publishing delays, Xie says, but «it will not have a serious
impact on scientific research.»
He also analyzes the pharmacogenomic data and their potential
impact on drug
approval and commercial sales.
Further
on he warns that in the oversight committee's next funding round in July, «negative decisions» about peer - reviewed grants awaiting the board's final
approval «would have a fatal
impact on CPRIT's peer review system» and would «be extremely harmful to the research community's view of science in Texas, and thus
on the ability to recruit scientists to the state.»
The lawsuit, filed in the U.S. Court of Appeals for the Ninth Circuit in California, argues that the Environmental Protection Agency (EPA) did not adequately analyze the
impact of one of the new herbicide's active ingredients, 2,4 - D, before granting
approval on Oct. 15 to Dow's Enlist Duo herbicide.
Nakamura said he would base his
approval on the construction ministry's assessment of the project's environmental
impact.
deCODE's actual results could differ materially from those anticipated in the forward - looking statements as a result of risks and uncertainties, including, without limitation, (1) the
impact of the announcement of its bankruptcy filing
on deCODE's operations; (2) the ability of deCODE to maintain sufficient debtor - in - possession financing to fund its operations and the expenses of the Chapter 11 proceeding; (3) the ability of deCODE to obtain court
approval of its motions in the Chapter 11 proceeding; (4) the outcome and timing of the proposed sale of deCODE's assets, including deCODE's ability to close a transaction with SagaInvestments, LLC or any other purchaser; (5) the uncertainty associated with motions by third parties in the bankruptcy proceeding; (6) deCODE's ability to obtain and maintain normal terms with vendors and service providers and contracts that are critical to its operation; and (7) other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report
on Form 10 - K and any updates to those risk factors filed from time to time in our Quarterly Reports
on Form 10 - Q or Current Reports
on Form 8 - K.
I never thought about the
impact I would have
on her, she looks up to me, cares what I think, watches my every move, wants my
approval, learns from me, and my biggest fan.
Other factors, such as our own proprietary website rules and the likelihood of applicants» credit
approval also
impact how and where products appear
on this site.
A good federal tax credit,
on the other hand,
impacts everyone and doesn't require state
approval, shielding it from teachers unions and state and local pols who would otherwise try to muck it up.
WASHINGTON — The
approval by the Congress last month of the most comprehensive revision of U.S. policy
on legal immigration in decades has left educators unsure about the bill's
impact on schools, with some experts warning that certain districts could see a new mix of immigrant students they are ill - prepared to handle.
As we learn more in the next few months about the review and
approval of these ESSA state accountability plans, it's important to understand that districts and schools will see the
impact of ESSA gradually over the next few years, as states begin to track the accountability data and report
on school success.
The discussion that led to Cortines» comments at the board meeting was the
approval of a new independent KIPP charter school, which spawned a wider discussion
on the financial
impact independent charter growth may be having
on the district, in particular a recent report from Moody's Investor Service that concluded that the coming expansion of KIPP charter schools in LA Unified was a credit negative, as it will result in a loss of $ 35 million to the district.
This report, from Self - Help, The A. J. Fletcher Foundation, and Public
Impact, reflects their thoughts
on policies, practices, and outcomes related to the state's charter application and
approval process, and the oversight and measurement of charter school performance.
IDRA's testimony, «The State of Texas Open - Enrollment Charter Schools and a Modest Proposal to Diversify and Improve Public Charter Schools,» focuses
on issues
impacting the Texas Senate's study of the
approval, expansion, and revocation of public charter schools in Texas, including the performance of charter schools in Texas and efficiency concerns related to the expanded funding of charter schools.
It was not until the 1970's, when the Fair Credit Reporting Act (FCRA) was passed, that borrowers were protected from lender bias having an
impact on their likelihood of loan
approval and rates.
Understanding the
impact on people that apply for payday loans and the people that don't make it through the
approval process.
Your credit score
impacts the interest rate you get
on a mortgage, a car loan, apartment leases, credit card
approvals, and even employment applications.